Black Doctors TV – Keloid Scarring

Recently, Sensus Healthcare’s CEO, Joe Sardano, was featured on a special episode on Black Doctors TV highlighting Superficial Radio Therapy (SRT) as being an effective solution for treating keloid scarring.

Keloids have been a serious health condition for far too long, particularly in the Black Community, with no definitive solution for a cure or treatment. The effects of keloids can significantly impact individuals’ lives. In this episode, Dr. Carl Truesdale, MD (www.doctortruesdale.com), provides medical information about what keloids are, how they can develop and the issues associated with this condition. Joe Sardano, provides information about their product, the SRT-100TM, a device that has a 94% cure rate for keloid scarring. Success stories with before and after photos are shared, showing the proven results of this device.

Watch the full episode below! If you would like to learn more about Superficial Radio Therapy (SRT) used to treat keloid scarring, contact us today.

Share this article

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

98.7%+
Non Reoccurrence Rate

No anesthesia, cutting, bleeding, stitching or pain

No downtime or lifestyle restrictions

Super cosmesis, no unsightly scarring

No need for post-treatment reconstructive surgeries

Patient Inquiry

Patient Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE

Physician Inquiry

Physician Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE

General Inquiry

General Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE